New therapeutic “cocktails” could offer long-lasting relief for treatment-resistant asthma and other inflammatory diseases of the immune system. Current asthma treatments are ineffective for some patients and do not provide long-term relief from potentially deadly asthma attacks. Scientists at La Jolla Institute for Immunology (LJI) are developing a new type of therapy.
Read more
